Gruppe B-streptokokker hos nyfødte og i de første tre levemåneder

Ida Nikoline Mandic, Victoria Elizabeth de Knegt, Hristo Stanchev, Tine Brink Henriksen, Emma Louise Malchau Carlsen, Maren Johanne Heilskov Rytter

1 Citationer (Scopus)

Abstract

Group B Streptococcus (GBS) disease in neonates occurs in two forms: early-onset disease (EOD), (day 0-6), and late-onset disease (LOD), (day 7-90). This review investigates that risk-based intrapartum screening and antibiotics have reduced the incidence of EOD, but not LOD, in Denmark. No clinical or laboratory tests can rule out GBS disease at symptom onset. Thus, a high proportion of uninfected infants receive antibiotics, although this varies widely, and may be reduced by strategies of antibiotic stewardship. A future GBS vaccine for pregnant women may potentially reduce disease burden and antibiotic exposure.

Bidragets oversatte titelGroup B streptococci in newborns in the first three months of life
OriginalsprogDansk
ArtikelnummerV01240022
TidsskriftUgeskrift for Laeger
Vol/bind186
Udgave nummer26
ISSN0041-5782
DOI
StatusUdgivet - 24 jun. 2024

Emneord

  • Humans
  • Streptococcal Infections/diagnosis
  • Infant, Newborn
  • Streptococcus agalactiae/isolation & purification
  • Anti-Bacterial Agents/therapeutic use
  • Female
  • Pregnancy
  • Denmark/epidemiology
  • Pregnancy Complications, Infectious/diagnosis
  • Infant
  • Streptococcal Vaccines/administration & dosage
  • Infectious Disease Transmission, Vertical/prevention & control

Fingeraftryk

Dyk ned i forskningsemnerne om 'Gruppe B-streptokokker hos nyfødte og i de første tre levemåneder'. Sammen danner de et unikt fingeraftryk.

Citationsformater